Maternal immunisation: ethical issues

The Lancet Infectious Diseases

Volumn 16, Issue 12, 2016, Pages e310-e314

  Verweij, Marcel ^a   Lambach, Philipp ^b   Ortiz, Justin R ^b   Reis, Andreas ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE; INFLUENZA VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID;

CHILD PROTECTION; DRUG SAFETY; ETHICAL DECISION MAKING; FEMALE; HUMAN; IMMUNIZATION; INFLUENZA VACCINATION; INFORMED CONSENT; MATERNAL CARE; PATIENT PARTICIPATION; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; TETANUS PROPHYLAXIS; ETHICS; INFANT; INFANT MORTALITY; INFLUENZA, HUMAN; MOTHER; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTIVE HEALTH SERVICE; PROCEDURES; VACCINATION;

FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT MORTALITY; INFLUENZA VACCINES; INFLUENZA, HUMAN; MOTHERS; PERTUSSIS VACCINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; TETANUS TOXOID; VACCINATION;

EID: 84992574512     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30349-8     Document Type: Review

References (30)

1. 1 WHO. Maternal and neonatal tetanus (MNT) elimination. http://www.who.int/immunization/diseases/MNTE_initiative/en/, 2015 (accessed Dec 16, 2015).
2. 2 Liu, L, Oza, S, Hogan, D, et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385 (2015), 430–440.
3. 3 WHO Position Papers. Vaccines against influenza. Wkly Epidemiol Rec 87 (2012), 461–476.
4. 4 Amirthalingam, G, Andrews, N, Campbell, H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 384 (2014), 1521–1528.
5. 5 Gezondheidsraad. Vaccinatie tegen kinkhoest: doel en strategie. Den Haag: Gezondheidsraad. Report No: 2015/29. https://www.gezondheidsraad.nl/nl/taak-werkwijze/werkterrein/preventie/vaccinatie-tegen-kinkhoest-doel-en-strategie, 2015 (accessed Sept 5, 2016).
6. 6 Bassat, Q, Maternal immunization: An intelligent solution to reduce the hidden burden of group B streptococcus perinatal disease. J Trop Pediatr 59 (2013), 333–337.
7. 7 Keller-Stanislawski, B, Englund, JA, Kang, G, et al. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 32 (2014), 7057–7064.
8. 8 Verweij, M, Dawson, A, Ethical principles for collective immunisation programmes. Vaccine 22 (2004), 3122–3126.
9. 9 Lindsey, B, Kampmann, B, Jones, C, Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis 26 (2013), 248–253.
10. 10 Castillo-Solórzano, C, Reef, SE, Morice, A, et al. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001–2008. J Infect Dis 204:suppl 2 (2011), S713–S717.
11. 11 Moro, PL, Broder, K, Zheteyeva, Y, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990–2009. Am J Obstet Gynecol 204 (2011), e1–e7.
12. 12 Nasidi, A, Monath, TP, Vandenberg, J, et al. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg 87 (1993), 337–339.
13. 13 Pasternak, B, Svanström, H, Mølgaard-Nielsen, D, et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 308 (2012), 165–174.
14. 14 Yuen, CYS, Tarrant, M, Determinants of uptake of influenza vaccination among pregnant women—a systematic review. Vaccine 32 (2014), 4602–4613.
15. 15 Wilson, RJ, Paterson, P, Jarrett, C, Larson, HJ, Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine 33 (2015), 6420–6429.
16. 16 Lewens, T, Taking sensible precautions. Lancet 371 (2008), 1992–1993.
17. 17 Sunstein, CR, Beyond the precautionary principle. Univ PA Law Rev 151 (2003), 1003–1058.
18. 18 Tubiana, M, Conclusions. The precautionary principle: its advantages and risks. Bull Acad Natl Med 184 (2000), 969–993.
19. 19 Little, MO, Treating important medical conditions during pregnancy. Enrolling pregnant women: issues in clinical research, Oct 18, 2010, National Institutes of Health, Bethesda, MD, 23–26.
20. 20 O'Neill, O, Some limits of informed consent. J Med Ethics 29 (2003), 4–7.
21. 21 Ruiz, JB, Bell, RA, Understanding vaccination resistance: vaccine search term selection bias and the valence of retrieved information. Vaccine 32 (2014), 5776–5780.
22. 22 O'Neill, O, Informed consent and public health. Philos Trans R Soc Lond B Biol Sci 359 (2004), 1133–1136.
23. 23 Nys, TRV, Paternalism in public health care. Public Health Ethics 1 (2008), 64–72.
24. 24 Purdy, LM, Are pregnant women fetal containers?. Bioethics 4 (1990), 273–291.
25. 25 Bhutta, ZA, Black, RE, Global maternal, newborn, and child health—so near and yet so far. N Engl J Med 369 (2013), 2226–2235.
26. 26 Ekman, B, Pathmanathan, I, Liljestrand, J, Integrating health interventions for women, newborn babies, and children: a framework for action. Lancet 372 (2008), 990–1000.
27. 27 Rosato, M, Laverack, G, Grabman, LH, et al. Community participation: lessons for maternal, newborn, and child health. Lancet 372 (2008), 962–971.
28. 28 Lambach, P, Alvarez, AMR, Hirve, S, et al. Considerations of strategies to provide influenza vaccine year round. Vaccine 33 (2015), 6493–6498.
29. 29 WHO. World Health Statistics 2015, 2015, World Health Organization, Geneva http://public.eblib.com/choice/publicfullrecord.aspx?p=2070501 (accessed Jan 14, 2016).
30. 30 Savitz, DA, Fell, DB, Ortiz, JR, Bhat, N, Does influenza vaccination improve pregnancy outcome? Methodological issues and research needs. Vaccine 33 (2015), 6430–6435.